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Rezumat. În articol sunt prezintate rezultatele determinării capacităţii de penetrare a flavolignanilor din armura-
riu, utilizând modele in vitro. Cea mai bună capacitate de penetrare a flavolignanilor este asigurată de combinaţia 
extractului uscat de armurariu cu suma saponinelor totale de lemn dulce (89,57% masă), standardului de silimarină 
cu aceleași saponine (85,75% masă), extractului uscat de armurariu cu lecitină de soia (84, 37% masă). La utilizarea 
dodecilsulfatului de sodiu (SDS), are loc o diferenţiere clară a curbelor de absorbţie, fapt ce permite utilizarea SDS 
ca model pentru studierea absorbţiei flavolignanilor.
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Abstract. The article presents the results of determining the penetrating ability of milk thistle flavolignans using in 
vitro models. The best penetrating abilityof flavolignans is provided by a combination of milk thistle dry extract with 
the total licorice saponins (89.57% by weight), standard of sylimarinewith saponins (85.75% by weight), dry extract 
with soy lecithin (84, 37% by weight). With the use of sodium dodecyl sulfate (SDS), a clear differentiation of the 
absorption curves occurs, which may allow the use of SDS as a model for studying the absorption of flavolignans.
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 INTRODUCTION
Dosage forms based on milk thistle fruits are widely 
represented on the modern pharmaceutical market and 
are used for pharmacotherapy of liver diseases such as 
alcoholic and non-alcoholic cirrhosis, drug liver pathology 
(DIL), viral hepatitis. The antitoxic, antioxidant, anti-in-
flammatory and antifibrotic effects of silymarin and po-
sitive effect on the processes of cellular regeneration of 
hepatocytes have been well studied.
Recent studies indicate the promise of using milk 
thistle flavolignans in the treatment of iron overload cau-
sed by β-thalassemia major, where silymarin is used as an 
adjuvant to standard iron chelators [1]. Research is also 
underway regarding its use in the complex therapy of 
prostate cancer [2].
The activity of silymarin against SARS-CoV-2 infection 
is currently being studied. It has been proven to work on 
multiple targets at once in the fight against COVID-19. Fir-
st, silibinin prevents the development of a cytokine storm 
in severe disease by directly inhibiting STAT3. Secondly, 
it is an inhibitor of RNA-dependent RNA polymerase, 
allowing effective suppression of viral replication, thereby 
reducing viral load [3]. Thirdly, during COVID-19 therapy, 
drugs can be used that negatively affect the liver, which 
justifies the use of silymarin as a hepatoprotector.
However, milk thistle flavolignans have low oral bioa-
vailability (the absolute bioavailability of silibinin is about 
0.95%) [4]. Therefore, this work will consider methods for 
increasing the bioavailability of silymarin and the nature 
of the penetrating ability of flavolignans through semi-
permeable membranes in vitro.
MATERIALS AND METHODS
The objects of research were a dry extract based on 
water-acetone extraction from crushed plant raw mate-
rials (Silybum marianum fructus manufactured by Biotest 
Ltd), «Legalon® 140» capsules, and a standard sample of 
silymarin for thin layer chromatography (TLC).
Dialysis membranes were used to study the penetra-
ting ability; Phosphate buffered saline with the addition 
of ursodeoxycholic acid and pancreatin, pH = 7.4, soluti-
on volume 3.6 ml, was used to simulate the intestinal en-
vironment. For the model of systemic blood flow, a similar 
buffer was used that did not contain bile acids and enzy-
mes, pH = 7.4, solution volume 18 ml.
Soy lecithin, sodium dodecyl sulfate (SDS), as well as 
the total triterpene saponins obtained by extraction with 
acetone and nitric acid (20: 1), followed by precipitation of 
the totalsaponins with an aqueous solution of ammonia 
from plant raw materials (Glycyrrhizae radices).
The incubation was carried out at 38.0 ° C for 6 hours. 
Sampling for spectrophotometry was carried out after 30, 
60, 90, 120, 180, 270 and 360 minutes.
The content of silymarin was determined spectrop-
hotometrically using the methodology of the State Phar-
macopoeia of the Republic of Belarus. The optical density 
was measured at a wavelength of 289 nm. The concentra-
tion (mg / ml) of silymarin was calculated using the for-
mula obtained on the basis of the calibration graph:
where A is the optical density of the test solution.
The data obtained was processed in Microsoft Office 
Excel 2016, the Data Analysis package. 
RESULTS AND DISCUSSIONS
Figure 1 shows the dependence of the concentration 




of penetrated flavolignans on the incubation time without 
the addition of surfactants. The charts have two mini-
mums: at 60 and 120 minutes. At 90 minutes, a peak is 
observed, then, starting from 180 minutes, the concen-
tration of penetrated silymarin increases, reaching its ma-
ximum at 270 minutes, after which it reaches a plateau. 
Table 1 shows the percentage of penetration of sily-
marin in the test samples. It follows from it that the grea-
test penetrating ability is possessed byLegalon® 140 
(69.83%).
 
Figure 1. Graphical dependence of the concentration (mg / ml)  
of penetrated flavolignans from time (min)
 Table 1. Mass fraction of flavolignans passed through the membrane
Initial weight of silymarin in 
solution, mg




Dry extract 1.4523 0.2748 18.92%
Legalon® 140 0.6231 0.4351 69.83%
Standard 1.2289 0.5430 44.18%
 Further, the stability of flavolignans in a buffer without 
the use of a membrane was investigated. Figure 2 shows 
the dependence of the concentration of flavolignans on 
the incubation time. It follows from this that the concen-
tration of flavolignans decreases sharply at 60 minutes, 
then increases again at 90 minutes and gradually decrea-
ses with further incubation.
Figure 3 shows the dependence of the concentration 
of penetrated flavolignans on the incubation time after 
adding 3% (by weight) soy lecithin to the test solutions, 
followed by filtration. The penetration curves for the dry 
extract and the standard of sylimarinhave the minimum 
concentration values  at the points corresponding to 30 
minutes of incubation, then a peak is observed at 90 mi-
nutes, after which the concentration decreases again and 
gradually reaches a plateau. Schedule forLegalon® 140 
has a slightly different character. It is observed at least 
at 30 minutes, however, in the time interval of 60-360 
minutes, fluctuations in concentration indicators are in-
significant.
Table 2 shows the percentage of silymarin penetrati-
on in the test samples after the addition of soy lecithin. 
It follows from it that the greatest penetrating ability is 
possessed bydry extract (84.37%).
 
Figure 2. Dependence of the concentration (mg / ml) of flavolignans on the incubation time (min)
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Figure 3. Graphical dependence of the concentration (mg / ml) of penetrated flavolignans on the  
time (min) after the addition of soy lecithin
Table 2. Mass fraction of flavolignans passed through the membrane after adding soy lecithin
Initial weight of silymarin in 
solution, mg




Dry extract 0.7453 0.6289 84.37%
Legalon® 140 1.5602 0.7164 45.92%
Standard 0.7818 0.4905 62.74%
 Figure 4 shows the dependence of the concentration 
of penetrated flavolignans on the incubation time after 
adding 3% (by weight) sodium dodecyl sulfate to the test 
solutions, followed by filtration. The graphs have a mini-
mum concentration at 30 minutes, a peak is observed at 
120 minutes, after which there is a slight decrease in con-
centration with a subsequent increase. No plateau at 360 
minutes is observed. 
Table 3 shows the percentage of penetration of si-
lymarin in the test samples after the addition of sodium 
dodecyl sulfate. It follows from it thatdry extract has the 
greatest penetrating ability (15.93%).
 
Figure 4. Graphical dependence of the concentration (mg / ml) of penetrated flavolignans versus 
time (min) after the addition of sodium dodecyl sulfate (SDS)
Table 3. Mass fraction of flavolignans passed through the membrane after adding sodium dodecyl 
sulfate (SDS)
Initial weight of silymarin 
in solution, mg




Dry extract 1.7988 0.2865 15.93%
Legalon® 140 2.9530 0.0817 2.77%
Standard 2.3448 0.1905 8.13%
 




Figure 5 shows the dependence of the concentration 
of penetrated flavolignans on the incubation time after 
adding 3% (by weight) of the totallicorice saponins to the 
test solutions, followed by filtration. Penetration graphs 
forLegalon® 140and standard have minimum concentra-
tion values at 60 and 120 minutes, a peak is observed at 
90 minutes. Schedule fordry extract has a maximum con-
centration at 30 minutes, minimum - at 60. The depen-
dence after 120 minutes for three samples is similar. At 
first, an increase in concentration is observed up to 270 
minutes, after which it decreases slightly. 
Table 4 shows the percentage of silymarin penetration 
in the test samples after adding total of the licorice sa-
ponins. It follows from it thatdry extract has the greatest 
penetrating ability (89.57%).
 
Figure 5. Graphical dependence of the concentration (mg / ml) of penetrated flavolignans on time 
(min) after adding the total licorice saponins
Table 4. Mass fraction of flavolignans passed through the membrane after adding the sum of licorice 
saponins
Initial weight of silymarin 
in solution, mg




Dry extract 3.4687 3.1068 89.57%
Legalon® 140 1.4277 1.1879 83.20%
Standard 2.4406 2.0927 85.75%
 Table 5 shows the penetration rates (in percent) of 
silymarin from pure samples and after the addition of va-
rious surfactants. It follows from this that the addition of 
soy lecithin increases the penetrating ability of flavolig-
nans by an average of 45.20%, total licorice saponins – by 
94.47% compared to the initial parameters. The addition 
of sodium dodecyl sulfate, on the other hand, reduces the 
passage of silymarin through the semipermeable mem-
brane by 79.82% compared to the initial one.
 Table 5. Percentage of penetration of flavolignans through the membrane
Dryextract Legalon® 140 Standard Average
No surfactant added 18.92% 69.83% 44.18% 44.31%
With added soy lecithin 84.37% 45.92% 62.74% 64.34%
With the addition of SDS 15.93% 2.77% 8.13% 8.94%
With the addition of the total 
licorice saponins 89.57% 83.20% 85.75% 86.17%
 




In the course of the work, it was experimentally found 
that the addition of various surfactants to varying degrees 
affects the penetrating ability of flavolignans in vitro. 
The best penetrating power is provided by a combina-
tion of dry extract with the total licorice saponins (89.57% 
by weight), standard of sylimarin with saponins (85.75% 
by weight), dry extract with soy lecithin (84,37% by wei-
ght). 
Samples with sodium dodecyl sulfate have the lowest 
penetration rates. Legalon® 140, standart and dry extract 
have penetration rates of 2.77%, 8.13% and 15.93% by 
weight, respectively. The addition of SDS shifts the peaks 
from 90 to 120 minutes, and there is also a clear differen-
tiation of the curves, which may allow the use of sodium 
dodecyl sulfate as a model for studying the absorption of 
silymarin.
The use of combined drugs based on milk thistle with 
lecithin, or milk thistle with licorice saponins has two ra-
tionales. Firstly, it will help to increase the bioavailability 
of silymarin in the gastrointestinal tract, which is rather 
low due to the poor solubility of flavolignans in water. Se-
condly, glycyrrhizic acid in the total licorice saponins, as 
well as phospholipids in lecithin, are themselves used for 
the prevention and treatment of liver diseases, and the 
combination of these substances can significantly incre-
ase the therapeutic effect of drugs based on them.
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